Navigation and service

You are here:Risk Assessment Procedures

Metamizole – inconsistent information regarding dosage and contraindications

Date 2018.06.04
Active substance Metamizol

04.06.2018 - procedure started

The European Medicines Agency (EMA) has started a review of medicines containing metamizole.

For details regarding the procedure please click on the following link to the European Medicines Agency (EMA):

Metamizole containing medicinal products